Abstract
Introduction: The predominant alterations in voice of patients with multiple sclerosis (MS) are phonatory instability, vocal asthenia and roughness, shortness of breath, hypophonia, and hypernasality. However, research on alterations of acoustic parameters has few studies and disparate results. The objective of this study was to investigate voice disturbances in patients with MS, both with objective measures (analysis of biomechanical) and subjective measures (scales and questionnaires). Methods: This is an experimental study with a total of 20 participants with MS. Voice samples were collected, and biomechanical correlates were analyzed through the Clinical Voice Systems program, Online Lab App. The VHI-30 (Voice Handicap Index) questionnaire, the GRBAS (grade, roughness, breathiness, asthenia, strain) scale, and the Hospital Anxiety and Depression Scale were used as subjective measures. Results: Ninety-five percentages of participants feel and describe dysphonic difficulties. Self-perception of vocal disability correlated with auditory vocal perceptual analysis in the sample of women. Conclusion: The biomechanical parameters showed alterations in the strength of the glottic closure, the efficiency index, and the structural imbalance index.
Journal Section:
Research Article
References
1.
Dobson
R
, Giovannoni
G
. Multiple sclerosis: a review
. Eur J Neurol
. 2019
;26
(1
):27
–40
. 2.
Zhang
T
, Zhang
Y
, Sun
H
, Shan
H
. Parkinson disease detection using energy direction features based on EMD from voice signal
. Biocybern Biomed Eng
. 2021
;41
(1
):127
–41
. 3.
Klineova
S
, Lublin
FD
. Clinical course of multiple sclerosis
. Cold Spring Harb Perspect Med
. 2018
;8
(9
):a028928
. 4.
El-Wahsh
S
, Bogaardt
H
, Kumfor
F
, Ballard
K
. Development and validation of the communication and language assessment questionnaire for persons with multiple sclerosis (CLAMS)
. Mult Scler Relat Disord
. 2020
;43
:102206
. 5.
Hartelius
L
, Runmarker
B
, Andersen
O
. Prevalence and characteristics of dysarthria in a multiple-sclerosis incidence cohort: relation to neurological data
. Folia Phoniatr Logop
. 2000
;52
(4
):160
–77
. 6.
Bauer
V
, Aleric
Z
, Jancic
E
, Knezevic
B
, Prpic
D
, Kacavenda
A
. Subjective and perceptual analysis of voice quality and relationship with neurological dysfunction in multiple sclerosis patients
. Clin Neurol Neurosurg
. 2013
;151
:S17
–20
. 7.
Taveira
FM
, Teixeira
AL
, Domingues
RB
. Early respiratory evaluation should be carried out systematically in patients with multiple sclerosis
. Arq Neuropsiquiatr
. 2013
;71
(3
):142
–5
. 8.
Sackley
CM
, Smith
CH
, Rick
CE
, Brady
MC
, Ives
N
, Patel
S
, et al. Lee Silverman Voice Treatment versus standard speech and language therapy versus control in Parkinson’s disease: a pilot randomised controlled trial (PD COMM pilot)
. Pilot Feasibility Stud
. 2018
;4
:30
. 9.
Matthews
PM
, Francis
G
, Antel
J
, Arnold
DL
. Proton magnetic resonance spectroscopy for metabolic characterization of plaques in multiple sclerosis
. Neurology
. 1991
;41
(8
):1251
–6
. 10.
Hamdan
AL
, Farhat
S
, Saadeh
R
, El-Dahouk
I
, Sibai
A
, Yamout
B
. Voice-related quality of life in patients with multiple sclerosis
. Autoimmune Dis
. 2012
;2012
:143813
. 11.
Martínez-Sánchez
F
, Meilán
JJG
, Carro
J
, Ivanova
O
. A prototype for the voice analysis diagnosis of Alzheimer’s disease
. J Alzheimers Dis
. 2018
;64
(2
):473
–81
. 12.
Vlaanderen
FP
, Rompen
L
, Munneke
M
, Stoffer
M
, Bloem
BR
, Faber
MJ
. The voice of the Parkinson customer
. J Parkinsons Dis
. 2019
;9
(1
):197
–201
. 13.
Bauer
V
, Aleric
Z
, Jancic
E
. Comparing voice self-assessment with auditory perceptual analysis in patients with multiple sclerosis
. Int Arch Otorhinolaryngol
. 2015
;19
(2
):100
–5
. 14.
Feijó
AV
, Parente
MA
, Behlau
M
, Haussen
S
, de Veccino
MC
, Martignago
BC
. Acoustic analysis of voice in multiple sclerosis patients
. J Voice
. 2004
;18
(3
):341
–7
. 15.
Konstantopoulos
K
, Vikelis
M
, Seikel
JA
, Mitsikostas
DD
. The existence of phonatory instability in multiple sclerosis: an acoustic and electroglottographic study
. Neurol Sci
. 2010
;31
(3
):259
–68
. 16.
Yamout
B
, Al-Zaghal
Z
, El-Dahouk
I
, Farhat
S
, Sibai
A
, Hamdan
ALH
. Mean contact quotient using electroglottography in patients with multiple sclerosis
. J Voice
. 2013
;27
(4
):506
–11
. 17.
Dogan
M
, Midi
I
, Yazici
MA
, Kocak
I
, Günal
D
, Sehitoglu
MA
. Objective and subjective evaluation of voice quality in multiple sclerosis
. J Voice
. 2007
;21
(6
):735
–40
. 18.
Cardoso
I
, Fernández-Baíllo
R
, Frutos
B
, Vittar
C
, Rodríguez
A
. Biomechanical analysis of the pattern of vocal production in students of interpretation
. Anales Otorrinolaringol Mex
. 2021
;66
(1
):15
–25
.19.
Cardoso
I
, Fernández-Baíllo
R
, Rodríguez
A
, Aparicio
G
, Hurtado
E
. Sensitivity of biomechanical analysis as a new tool for the screening of dysphonia
. Rev Asoc Esp Espec Med Trab
. 2021
;30
(1
):81
–9
.20.
Fernández-Baillo
R
, Ramírez-Calvo
R
, Ruíz-Galea
JI
. Biomechanical analysis of voice. Voice clinical systems
. 1st ed. Madrid
; 2017
.21.
Gómez-Vilda
P
, Fernández-Baillo
R
, Nieto
A
, Díaz
F
, Fernández-Camacho
FJ
, Rodellar
V
, et al. Evaluation of voice pathology based on the estimation of vocal fold biomechanical parameters
. J Voice
. 2007
;21
(4
):450
–76
. 22.
Romero-Arias
T
, Betancort-Montesinos
M
. Voice sequelae following recovery from COVID-19
. J Voice
. 2022
;S0892-1997
(22
):00196-5
. 23.
Romero-Arias
T
, Redondo
I
, Pérez
A
. Biomechanical parameters of voice in Parkinson’s disease patients
. Folia Phoniatr Logop
. 2023
;76
(1
):91
–101
. 24.
Wallace
J
, Kanegaonkar
R
. The role of smartphone applications in clinical practice: a review
. J Laryngol Otol
. 2020
;134
(2
):96
–103
. 25.
Jacobson
BH
, Johnson
A
, Grywalski
C
, Silbergleit
A
, Jacobson
G
, Benninger
MS
, et al. The voice handicap index (VHI): development and validation
. Am J Speech Lang Pathol
. 1997
;6
(3
):66
–70
. 26.
Núñez-Batalla
F
, Corte-Santos
P
, Señaris-González
B
, Llorente-Pendás
JL
, Górriz-Gil
C
, Suárez-Nieto
C
. Adaptation and validation to the Spanish of the voice handicap index (VHI-30) and its shortened version (VHI-10)
. Acta Otorrinolaringol Esp
. 2007
;58
(9
):386
–92
. 27.
28.
Zigmond
AS
, Snaith
RP
. The hospital anxiety and depression scale
. Acta Psychiatr Scand
. 1983
;67
(6
):361
–70
. 29.
Herrero
MJ
, Blanch
J
, Peri
JM
, De Pablo
J
, Pintor
L
, Bulbena
A
. A validation study of the hospital anxiety and depression scale (HADS) in a Spanish population
. Gen Hosp Psychiatry
. 2003
;25
(4
):277
–83
. 30.
Aguilar-Falomir
J
, Álvarez Bardón
I
, Balmaseda-Álvarez
MC
, Blasco Ibañez
V
, Gil Juliá
B
. Implicaciones psicológicas de la esclerosis múltiple. Un estudio preliminar
. Revista Española de Neuropsicología
. 2019
;21
(3
):369
–78
.31.
Olivares-Pérez
T
, Nieto-Barco
A
, Betancort-Montesinos
M
, Pérez-Martín
Y
, Hernández-Pérez
MÁ
, Barroso-Ribal
J
. Ansiedad y depresión en la esclerosis múltiple remitente-recidivante: relación con las alteraciones neuropsicológicas y la percepción subjetiva de deterioro cognitivo en pacientes con discapacidad mínima/leve
. Revista Chilena de Neuropsicología
. 2009
;4
(1
):44
–51
.32.
Fàbregas
L
, Planes
M
, Eugenia Gras
M
, Ramió-Torrentà
L
. Calidad de vida de los pacientes recién diagnosticados de esclerosis múltiple: influencia de las variables físicas y psicosociales
. Med Clin
. 2007
;128
(9
):355
–6
. 33.
Schober
P
, Boer
C
, Schwarte
L
. Correlation coefficients: appropriate use and interpretation
. Anesth Analg
. 2018
;126
(5
):1763
–8
. 34.
Duranovic
M
, Salihovic
N
, Ibrahimagic
A
, Toromanovic
N
. Characteristics of voice in individuals with multiple sclerosis
. Mater Sociomed
. 2011
;23
(1
):23
.35.
Fazeli
M
, Moradi
N
, Soltani
M
, Naderifar
E
, Majdinasab
N
, Latifi
SM
. Comparison of dysphonia severity index and its parameters among individuals with multiple sclerosis and healthy subjects
. Shiraz E-med J
. 2018
;19
(7
). 36.
Vizza
P
, Tradigo
G
, Mirarchi
D
, Bossio
RB
, Veltri
P
. On the use of voice signals for studying sclerosis disease
. Computers
. 2017
;6
(4
):30
. © 2024 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2024
You do not currently have access to this content.
